[
    {
        "text": "this is the fastest i ever have worked",
        "start": 0.88,
        "duration": 4.16
    },
    {
        "text": "for any vaccine throughout my third year",
        "start": 3.04,
        "duration": 3.359
    },
    {
        "text": "of career",
        "start": 5.04,
        "duration": 3.519
    },
    {
        "text": "one thing i knew that we do not have",
        "start": 6.399,
        "duration": 3.441
    },
    {
        "text": "time that normally",
        "start": 8.559,
        "duration": 3.521
    },
    {
        "text": "vaccine takes a number of years to",
        "start": 9.84,
        "duration": 3.2
    },
    {
        "text": "develop",
        "start": 12.08,
        "duration": 4.16
    },
    {
        "text": "so we have to work in accelerated time",
        "start": 13.04,
        "duration": 4.88
    },
    {
        "text": "frame",
        "start": 16.24,
        "duration": 3.6
    },
    {
        "text": "i like to do everything accomplished",
        "start": 17.92,
        "duration": 4.24
    },
    {
        "text": "like today there is no tomorrows",
        "start": 19.84,
        "duration": 5.12
    },
    {
        "text": "i work maybe 18 20 hour you know i",
        "start": 22.16,
        "duration": 4.48
    },
    {
        "text": "barely sleep four hours",
        "start": 24.96,
        "duration": 4.319
    },
    {
        "text": "people ask me you know if i'm tired um i",
        "start": 26.64,
        "duration": 4.16
    },
    {
        "text": "don't feel tired",
        "start": 29.279,
        "duration": 3.761
    },
    {
        "text": "nida patel is a senior director in the",
        "start": 30.8,
        "duration": 3.919
    },
    {
        "text": "vaccine development department",
        "start": 33.04,
        "duration": 4.88
    },
    {
        "text": "at novofax a small biotech company in",
        "start": 34.719,
        "duration": 5.041
    },
    {
        "text": "gaithersburg maryland",
        "start": 37.92,
        "duration": 3.92
    },
    {
        "text": "she and her team have been critical to",
        "start": 39.76,
        "duration": 5.2
    },
    {
        "text": "developing a promising covid19 vaccine",
        "start": 41.84,
        "duration": 6.239
    },
    {
        "text": "in just 10 months",
        "start": 44.96,
        "duration": 7.04
    },
    {
        "text": "i have you know molecular neurologists",
        "start": 48.079,
        "duration": 7.201
    },
    {
        "text": "antibody specialist immunologists and",
        "start": 52.0,
        "duration": 6.0
    },
    {
        "text": "associates in the team and they are all",
        "start": 55.28,
        "duration": 4.88
    },
    {
        "text": "very expert in what they do",
        "start": 58.0,
        "duration": 5.199
    },
    {
        "text": "so we doing so many experiments so many",
        "start": 60.16,
        "duration": 3.76
    },
    {
        "text": "analyses",
        "start": 63.199,
        "duration": 3.6
    },
    {
        "text": "at the same time one challenging thing",
        "start": 63.92,
        "duration": 3.519
    },
    {
        "text": "for me",
        "start": 66.799,
        "duration": 2.64
    },
    {
        "text": "having so many scientists working",
        "start": 67.439,
        "duration": 4.161
    },
    {
        "text": "different things keep them motivated",
        "start": 69.439,
        "duration": 4.961
    },
    {
        "text": "that okay we are getting there one more",
        "start": 71.6,
        "duration": 5.76
    },
    {
        "text": "experiment we're gonna know the answers",
        "start": 74.4,
        "duration": 5.359
    },
    {
        "text": "planning and communicating every",
        "start": 77.36,
        "duration": 3.119
    },
    {
        "text": "scientist",
        "start": 79.759,
        "duration": 3.841
    },
    {
        "text": "every day sometimes couple times a day",
        "start": 80.479,
        "duration": 6.081
    },
    {
        "text": "and being with them in the lab it's a",
        "start": 83.6,
        "duration": 4.8
    },
    {
        "text": "key to get to the point where we are",
        "start": 86.56,
        "duration": 3.199
    },
    {
        "text": "today",
        "start": 88.4,
        "duration": 3.52
    },
    {
        "text": "patel's passion to develop vaccines",
        "start": 89.759,
        "duration": 4.081
    },
    {
        "text": "against infectious diseases",
        "start": 91.92,
        "duration": 5.12
    },
    {
        "text": "led her to novavax five years ago",
        "start": 93.84,
        "duration": 6.16
    },
    {
        "text": "so my career started as a scientist",
        "start": 97.04,
        "duration": 3.6
    },
    {
        "text": "making",
        "start": 100.0,
        "duration": 3.84
    },
    {
        "text": "a vaccine at marymun my dad",
        "start": 100.64,
        "duration": 6.0
    },
    {
        "text": "has become handicapped at very young age",
        "start": 103.84,
        "duration": 4.48
    },
    {
        "text": "because of the tuberculosis",
        "start": 106.64,
        "duration": 4.799
    },
    {
        "text": "so that was my motivation to start my",
        "start": 108.32,
        "duration": 4.799
    },
    {
        "text": "first project as a tv",
        "start": 111.439,
        "duration": 4.561
    },
    {
        "text": "vaccine project i always been in a",
        "start": 113.119,
        "duration": 4.241
    },
    {
        "text": "vaccine area",
        "start": 116.0,
        "duration": 3.0
    },
    {
        "text": "lyme disease vaccine human",
        "start": 117.36,
        "duration": 5.119
    },
    {
        "text": "papillomavirus vaccine malaria vaccine",
        "start": 119.0,
        "duration": 7.0
    },
    {
        "text": "rsv vaccine influenza vaccines",
        "start": 122.479,
        "duration": 5.521
    },
    {
        "text": "our sweet vaccine was near and dear to",
        "start": 126.0,
        "duration": 3.599
    },
    {
        "text": "my heart as i have",
        "start": 128.0,
        "duration": 3.68
    },
    {
        "text": "was instrumental in developing",
        "start": 129.599,
        "duration": 4.0
    },
    {
        "text": "television map which is also called",
        "start": 131.68,
        "duration": 2.96
    },
    {
        "text": "synergies",
        "start": 133.599,
        "duration": 3.201
    },
    {
        "text": "that the only one available for",
        "start": 134.64,
        "duration": 4.16
    },
    {
        "text": "premature babies can save",
        "start": 136.8,
        "duration": 5.2
    },
    {
        "text": "from rso infection as a therapy if i can",
        "start": 138.8,
        "duration": 5.6
    },
    {
        "text": "bring our suite vaccine to the market",
        "start": 142.0,
        "duration": 5.28
    },
    {
        "text": "that would be my home run for my career",
        "start": 144.4,
        "duration": 5.44
    },
    {
        "text": "novovax's rsv vaccine attacks a",
        "start": 147.28,
        "duration": 4.88
    },
    {
        "text": "respiratory virus that kills tens of",
        "start": 149.84,
        "duration": 4.16
    },
    {
        "text": "thousands of young kids in developing",
        "start": 152.16,
        "duration": 3.2
    },
    {
        "text": "countries",
        "start": 154.0,
        "duration": 4.0
    },
    {
        "text": "it has twice failed in clinical trials",
        "start": 155.36,
        "duration": 5.76
    },
    {
        "text": "but the company hasn't given up on it",
        "start": 158.0,
        "duration": 5.36
    },
    {
        "text": "novovax has never brought a vaccine to",
        "start": 161.12,
        "duration": 3.36
    },
    {
        "text": "market",
        "start": 163.36,
        "duration": 2.879
    },
    {
        "text": "but the ones they develop share a",
        "start": 164.48,
        "duration": 3.36
    },
    {
        "text": "similar approach",
        "start": 166.239,
        "duration": 4.481
    },
    {
        "text": "using a viral protein and an adjuvant an",
        "start": 167.84,
        "duration": 4.24
    },
    {
        "text": "immune boosting compound",
        "start": 170.72,
        "duration": 4.72
    },
    {
        "text": "to elicit an immune response in the body",
        "start": 172.08,
        "duration": 5.76
    },
    {
        "text": "novovax produces the coronavirus spike",
        "start": 175.44,
        "duration": 3.04
    },
    {
        "text": "protein",
        "start": 177.84,
        "duration": 3.039
    },
    {
        "text": "by infecting moth cells with viruses",
        "start": 178.48,
        "duration": 7.119
    },
    {
        "text": "that contain the spike protein's dna",
        "start": 180.879,
        "duration": 6.401
    },
    {
        "text": "after harvesting the spike from the",
        "start": 185.599,
        "duration": 3.521
    },
    {
        "text": "membrane of millions of cells",
        "start": 187.28,
        "duration": 4.56
    },
    {
        "text": "the spikes embed in a tiny soap-like",
        "start": 189.12,
        "duration": 4.56
    },
    {
        "text": "particle",
        "start": 191.84,
        "duration": 4.24
    },
    {
        "text": "the resulting spike-studded cylinders",
        "start": 193.68,
        "duration": 3.199
    },
    {
        "text": "are the right",
        "start": 196.08,
        "duration": 3.2
    },
    {
        "text": "virus-like size for the immune system to",
        "start": 196.879,
        "duration": 4.481
    },
    {
        "text": "recognize them as a danger scientists",
        "start": 199.28,
        "duration": 3.44
    },
    {
        "text": "believe",
        "start": 201.36,
        "duration": 4.159
    },
    {
        "text": "so the three key features we were",
        "start": 202.72,
        "duration": 4.159
    },
    {
        "text": "looking into the vaccine",
        "start": 205.519,
        "duration": 4.08
    },
    {
        "text": "and we found one which has all three",
        "start": 206.879,
        "duration": 5.201
    },
    {
        "text": "first one was to have to have a protein",
        "start": 209.599,
        "duration": 5.681
    },
    {
        "text": "in a prefusion form the receptor binding",
        "start": 212.08,
        "duration": 3.76
    },
    {
        "text": "domain",
        "start": 215.28,
        "duration": 4.8
    },
    {
        "text": "are in upper position so we were looking",
        "start": 215.84,
        "duration": 6.959
    },
    {
        "text": "a strong s2 receptor binding",
        "start": 220.08,
        "duration": 4.4
    },
    {
        "text": "characteristic of our",
        "start": 222.799,
        "duration": 4.401
    },
    {
        "text": "protein as well as the stability of the",
        "start": 224.48,
        "duration": 3.52
    },
    {
        "text": "protein",
        "start": 227.2,
        "duration": 3.36
    },
    {
        "text": "at certain temperature and also the",
        "start": 228.0,
        "duration": 5.439
    },
    {
        "text": "immunogenicity at the same time",
        "start": 230.56,
        "duration": 6.48
    },
    {
        "text": "we made over 20 construct of a kovid",
        "start": 233.439,
        "duration": 6.641
    },
    {
        "text": "vaccine he found one that has a right",
        "start": 237.04,
        "duration": 4.8
    },
    {
        "text": "conformation",
        "start": 240.08,
        "duration": 3.519
    },
    {
        "text": "we found the right vaccine but there is",
        "start": 241.84,
        "duration": 4.16
    },
    {
        "text": "a lot more things that we are still",
        "start": 243.599,
        "duration": 5.36
    },
    {
        "text": "involved but we also look at the quality",
        "start": 246.0,
        "duration": 4.879
    },
    {
        "text": "of the immune response the protective",
        "start": 248.959,
        "duration": 3.041
    },
    {
        "text": "immune response",
        "start": 250.879,
        "duration": 5.521
    },
    {
        "text": "that that we our vaccine has generated",
        "start": 252.0,
        "duration": 5.919
    },
    {
        "text": "early clinical trials have been",
        "start": 256.4,
        "duration": 4.64
    },
    {
        "text": "promising after exposing monkeys to sars",
        "start": 257.919,
        "duration": 3.84
    },
    {
        "text": "cov2",
        "start": 261.04,
        "duration": 3.12
    },
    {
        "text": "weeks after they were vaccinated the",
        "start": 261.759,
        "duration": 3.601
    },
    {
        "text": "virus completely",
        "start": 264.16,
        "duration": 2.96
    },
    {
        "text": "failed to replicate in the animal's",
        "start": 265.36,
        "duration": 3.04
    },
    {
        "text": "noses",
        "start": 267.12,
        "duration": 3.6
    },
    {
        "text": "but the results from larger human trials",
        "start": 268.4,
        "duration": 3.6
    },
    {
        "text": "aren't in yet",
        "start": 270.72,
        "duration": 3.919
    },
    {
        "text": "and novovax is just now confronting its",
        "start": 272.0,
        "duration": 4.08
    },
    {
        "text": "biggest hurdle",
        "start": 274.639,
        "duration": 4.401
    },
    {
        "text": "scaling its vaccine manufacturing they",
        "start": 276.08,
        "duration": 3.839
    },
    {
        "text": "will have to rely",
        "start": 279.04,
        "duration": 2.8
    },
    {
        "text": "heavily on partners to produce their",
        "start": 279.919,
        "duration": 4.081
    },
    {
        "text": "vaccine",
        "start": 281.84,
        "duration": 3.919
    },
    {
        "text": "novovac says the experienced",
        "start": 284.0,
        "duration": 3.6
    },
    {
        "text": "manufacturers they will work with",
        "start": 285.759,
        "duration": 4.081
    },
    {
        "text": "like the serum institute of india will",
        "start": 287.6,
        "duration": 6.64
    },
    {
        "text": "help them create 2 billion doses in 2021",
        "start": 289.84,
        "duration": 6.72
    },
    {
        "text": "although up against larger more seasoned",
        "start": 294.24,
        "duration": 3.519
    },
    {
        "text": "competitors",
        "start": 296.56,
        "duration": 4.479
    },
    {
        "text": "novovax's covid19 vaccine may just be",
        "start": 297.759,
        "duration": 5.361
    },
    {
        "text": "their first to go the distance and make",
        "start": 301.039,
        "duration": 4.321
    },
    {
        "text": "it on the market",
        "start": 303.12,
        "duration": 4.48
    },
    {
        "text": "i can't wait to see this vaccine",
        "start": 305.36,
        "duration": 3.04
    },
    {
        "text": "deployed",
        "start": 307.6,
        "duration": 14.48
    },
    {
        "text": "and i probably the first one to get",
        "start": 308.4,
        "duration": 13.68
    }
]